Spanish Biotech Stock News

BME:BBVA
BME:BBVABanks

A Look At BBVA (BME:BBVA) Valuation After Earnings Beat, Fitch Upgrade And New Share Buybacks

The recent jump in Banco Bilbao Vizcaya Argentaria (BME:BBVA) stock is closely tied to several overlapping drivers: firm first quarter results, a Fitch credit rating upgrade, and fresh momentum in the bank’s ongoing and new share buyback programs. See our latest analysis for Banco Bilbao Vizcaya Argentaria. Set against a 1 year total shareholder return of 48.11% and a very large 5 year total shareholder return of 391.39%, the recent 1 day share price gain of 3.81% to €19.47 and the 7 day...
BME:TRE
BME:TREEnergy Services

Assessing Técnicas Reunidas (BME:TRE) Valuation After Mixed First Quarter 2026 Results

Técnicas Reunidas (BME:TRE) drew fresh attention after releasing first quarter 2026 results, reporting sales of €1,582.7 million and revenue of €1,585 million, while net income of €14.9 million compared to €27.2 million a year earlier. See our latest analysis for Técnicas Reunidas. The €30.76 share price has seen a 4.98% 1 day share price gain after the first quarter results. However, the share price remains down 10.48% over 30 days and 11.35% over 90 days, while the 1 year total shareholder...
BME:MAP
BME:MAPInsurance

A Look At Mapfre (BME:MAP) Valuation After Its Strong Solvency Ratio And New Dividend Announcement

Mapfre (BME:MAP) has attracted fresh attention after reporting a solvency ratio of 206.8% alongside plans to pay a complementary dividend of €0.11 per share on May 28, two developments that income focused investors are watching closely. See our latest analysis for Mapfre. Alongside the upcoming dividend and robust solvency ratio, Mapfre’s €4.224 share price has seen steadier momentum over the past quarter, with a 90 day share price return of 8.2%. The 1 year total shareholder return of 25.76%...
BME:SAN
BME:SANBanks

How Investors May Respond To Banco Santander (BME:SAN) Fitch Upgrade, Record Profit And TSB Acquisition

In recent days, Banco Santander reported that Fitch Ratings upgraded its Long-Term Issuer Default Rating to ‘A+’ from ‘A’, alongside record Q1 2026 profit, robust revenue growth and the completed €3.30 billion acquisition of TSB, Banco Sabadell’s British subsidiary. This combination of a higher credit rating, stronger earnings and UK expansion via TSB adds a new dimension to how investors may assess Santander’s business quality and risk profile. With Fitch’s upgrade signalling enhanced...
BME:COXG
BME:COXGRenewable Energy

Undiscovered European Gems With Promising Potential May 2026

As the European markets navigate through geopolitical tensions and inflationary pressures, the pan-European STOXX Europe 600 Index recently ended a week down by 0.85%, reflecting broader market challenges. Despite these headwinds, robust corporate earnings growth signals potential opportunities for discerning investors seeking to identify promising stocks that can thrive amidst economic uncertainties. In such an environment, a good stock might be characterized by strong fundamentals and...
BME:REP
BME:REPOil and Gas

Repsol (BME:REP) Valuation Check As Alaska Pikka Oil Production Reaches First Output

Santos has started oil production at the Pikka phase one project on Alaska’s North Slope, where Repsol (BME:REP) holds a 49% stake. This development puts the Spanish energy group’s upstream exposure in sharper focus. See our latest analysis for Repsol. Against this backdrop, Repsol’s recent momentum has been strong, with a 30 day share price return of 12.01%, a year to date share price return of 37.54%, and a one year total shareholder return above 100%. This points to investors reassessing...
BME:ALM
BME:ALMPharmaceuticals

A Look At Almirall (BME:ALM) Valuation After Q1 Results Dividend Approval And Stock Split Announcement

Almirall (BME:ALM) has given investors a cluster of fresh information, combining first quarter 2026 results with reiterated full year net sales guidance, a confirmed dividend and an upcoming stock split. See our latest analysis for Almirall. Despite the fresh guidance, dividend approval and upcoming stock split, momentum in the share price has cooled, with the stock down 11.8% year to date on a share price basis. However, the 3 year total shareholder return of 42.1% points to a stronger...
BME:TEF
BME:TEFTelecom

Telefónica (BME:TEF) Valuation Check As Q1 2026 Results Show Higher Sales And A Smaller Net Loss

How Telefónica’s latest earnings set the stage for investors Telefónica (BME:TEF) has just reported first quarter 2026 results, giving you fresh numbers to assess the stock. The update mixes higher sales with a smaller net loss and shifting earnings per share. See our latest analysis for Telefónica. The earnings release comes after a strong run in the share price, with a 90 day share price return of 13.47% and a year to date share price return of 17.15%, even though the 1 year total...
BME:SLR
BME:SLRRenewable Energy

Solaria Energía y Medio Ambiente (BME:SLR) Q1 EPS Rebound Tests Earnings Volatility Concerns

Solaria Energía y Medio Ambiente (BME:SLR) opened Q1 2026 with revenue of €120.4 million and basic EPS of €0.66, while its trailing 12 month line shows revenue of €342.4 million and EPS of €1.36. Over recent quarters the company has seen revenue move from €81 million in Q1 2025 to €120.4 million in Q1 2026, with basic EPS shifting from €0.23 in Q2 2025 and a small loss in Q4 2025 to €0.66 in the latest quarter. This sets up a story in which already high net margins keep the focus squarely on...
BME:ELE
BME:ELEElectric Utilities

Did Stronger Q1 2026 Profitability Amid Softer Sales Just Shift Endesa’s (BME:ELE) Investment Narrative?

Endesa, S.A. recently reported first-quarter 2026 results, with sales of €5,729 million and revenue of €5,824 million, while net income rose to €725 million and basic earnings per share from continuing operations reached €0.696. The combination of slightly lower sales but higher earnings and earnings per share points to improved profitability and cost efficiency in Endesa’s operations. Next, we’ll consider how this stronger first-quarter profitability, despite softer sales, may influence...
BME:REP
BME:REPOil and Gas

Is It Too Late To Consider Repsol (BME:REP) After A 112% One-Year Surge?

If you are wondering whether Repsol stock still offers value after a strong run, or if most of the opportunity is already reflected in the price, this article walks through the key numbers that matter for you. Repsol recently closed at €23.53, with returns of 5.4% over the past week, 19.3% over the past month, 43.4% year to date, and 112.6% over the last year. This has sharpened the focus on what investors are now paying for each euro of earnings and cash flow. Recent headlines around Repsol...
BME:TLGO
BME:TLGOMachinery

European Stocks Estimated To Be Trading Below Fair Value In May 2026

Despite robust earnings growth across European corporations, the region's stock markets have been under pressure due to geopolitical tensions and rising energy prices, which could lead to inflationary pressures and higher interest rates. In this environment, identifying stocks trading below their fair value can be a strategic approach for investors seeking opportunities amidst broader market uncertainties.
BME:ECR
BME:ECRChemicals

Ercros (BME:ECR) Q1 Losses Deepen And Reinforce Bearish Earnings Narratives

Ercros (BME:ECR) opened 2026 with Q1 revenue of €154.3 million and a basic EPS loss of €0.15, as net income excluding extra items came in at a loss of €13.6 million. The company has seen quarterly revenue move between €136.5 million and €178.6 million since early 2025, while basic EPS losses over the reported periods have ranged from €0.04 to €0.19. This gives investors a clear view of pressure on the income statement even as the top line holds in the mid hundreds of millions. With the stock...
BME:FDR
BME:FDRMachinery

Is It Time To Revisit Fluidra (BME:FDR) After Recent Share Price Weakness?

Wondering whether Fluidra at €18.62 is starting to look like value or still has room to fall further? This article breaks down what the current price may be implying. The stock is down 3.2% over the past week, 14.4% over the past month, 20.8% year to date and 12.2% over the past year. The 3 year return stands at 20.6%, and the 5 year return shows a decline of 33.3%. Recent market commentary around Fluidra has focused on how these mixed return figures over different time frames may reflect...
BME:ITX
BME:ITXSpecialty Retail

A Look At Inditex (BME:ITX) Valuation After A Sharp Session Share Price Drop

Industria de Diseño Textil (BME:ITX) drew fresh attention after its share price fell 2.63% in a session in which broader Consumer Goods weakness also pulled the IBEX 35 index down 0.21%. See our latest analysis for Industria de Diseño Textil. That sharp daily setback comes after a period in which momentum has been fading, with the 30 day share price return down 6.32% and the year to date share price return down 12.18%, even as the 5 year total shareholder return sits at 75.92%. If this kind...
BME:TRE
BME:TREEnergy Services

Técnicas Reunidas (BME:TRE) Margin Uptick To 2.4% Tests Bullish Earnings Narrative

Técnicas Reunidas (BME:TRE) has kicked off its Q1 2026 reporting cycle on the back of a solid run, with Q4 2025 revenue at about €1.9b and net income of €49.8m, translating into basic EPS of €0.64. Over the past year, the company has seen total revenue move from €1.2b in Q4 2024 to €1.9b in Q4 2025, while basic EPS over the trailing twelve months reached €1.98 as net income climbed to €156.7m. This places margins and earnings at the center of how investors may interpret the latest update. See...
BME:ORY
BME:ORYBiotechs

Oryzon Genomics (BME:ORY) Losses Narrowing Tests Bullish Profitability Narratives

Oryzon Genomics (BME:ORY) has opened 2026 earnings season with Q1 numbers that sit against a backdrop of quarterly revenue of €12.8 million and a basic EPS loss of €0.02 in Q4 2025. Over the last reported periods, the company has seen quarterly revenue move between €4.97 million and €12.8 million, while basic EPS has remained in loss-making territory in both euro and US dollar terms. With forecasts pointing to changes in revenue and EPS alongside an expected shift toward profitability within...